U.S. flag

An official website of the United States government

NM_004959.5(NR5A1):c.48C>A (p.Cys16Ter) AND 46,XY sex reversal 3

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Oct 1, 2004
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000013642.24

Allele description [Variation Report for NM_004959.5(NR5A1):c.48C>A (p.Cys16Ter)]

NM_004959.5(NR5A1):c.48C>A (p.Cys16Ter)

Gene:
NR5A1:nuclear receptor subfamily 5 group A member 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
9q33.3
Genomic location:
Preferred name:
NM_004959.5(NR5A1):c.48C>A (p.Cys16Ter)
HGVS:
  • NC_000009.12:g.124503348G>T
  • NG_008176.1:g.9073C>A
  • NM_004959.5:c.48C>AMANE SELECT
  • NP_004950.2:p.Cys16Ter
  • NC_000009.11:g.127265627G>T
Protein change:
C16*; CYS16TER
Links:
OMIM: 184757.0005; dbSNP: rs104894123
NCBI 1000 Genomes Browser:
rs104894123
Molecular consequence:
  • NM_004959.5:c.48C>A - nonsense - [Sequence Ontology: SO:0001587]

Condition(s)

Name:
46,XY sex reversal 3
Synonyms:
SEX REVERSAL, XY, WITH OR WITHOUT ADRENAL FAILURE; 46,XY SEX REVERSAL, PARTIAL OR COMPLETE, NR5A1-RELATED; NR5A1-Related 46,XY CGD; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0013066; MedGen: C3489793; OMIM: 612965

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000033889OMIM
no assertion criteria provided
Pathogenic
(Oct 1, 2004)
germlineliterature only

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only

Citations

PubMed

Gonadal dysgenesis without adrenal insufficiency in a 46, XY patient heterozygous for the nonsense C16X mutation: a case of SF1 haploinsufficiency.

Mallet D, Bretones P, Michel-Calemard L, Dijoud F, David M, Morel Y.

J Clin Endocrinol Metab. 2004 Oct;89(10):4829-32.

PubMed [citation]
PMID:
15472171

Details of each submission

From OMIM, SCV000033889.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (1)

Description

In a 46,XY patient showing gonadal dysgenesis with normal adrenal function (SRXY3; 612965), Mallet et al. (2004) reported a heterozygous SF1 gene mutation, a C-to-A transversion in exon 2 that replaced cys16 with a stop codon (C16X). The patient showed low basal levels of anti-mullerian hormone (600957) and testosterone (T), weak T response to chorionic gonadotropin (see 118860), and hypoplastic testes with abundant seminiferous tubules but rare germ cells. This mutation caused premature termination of translation and should abolish all SF1 activity; therefore, haploinsufficiency could explain the deleterious effect of this mutation, suggesting that testis development is more SF1 dose-dependent than adrenal development. The authors concluded that heterozygous mutation can impair adrenal development only if the 2 mechanisms, gene dosage and dominant-negative effects, occur.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

Last Updated: Apr 23, 2022